Aksh Optifibre Announcements
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended March, 2026
07 Apr, 2026 | 03:53pm • Source: BSE
Intimation of Regulation 30 under SEBI (LODR) Regulations, 2015
27 Mar, 2026 | 06:08pm • Source: BSE
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
25 Mar, 2026 | 05:36pm • Source: BSE
Intimation of closure of trading window
24 Mar, 2026 | 04:32pm • Source: BSE
Unaudited Financial Results (Standalone & Consolidated) for the Quarter & Nine Months ended December 31, 2025
06 Feb, 2026 | 05:35pm • Source: BSE
Outcome of Board Meeting for Consideration & Approval of Unaudited Financial Results (Standalone & Consolidated) for the Quarter & Nine Months Ended December 31, 2025
06 Feb, 2026 | 05:27pm • Source: BSE
Aksh Optifibre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and...
22 Jan, 2026 | 04:30pm • Source: BSE
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
07 Jan, 2026 | 04:31pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudfhari
31 Dec, 2025 | 03:19pm • Source: BSE
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015.
30 Dec, 2025 | 05:55pm • Source: BSE
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
26 Dec, 2025 | 05:41pm • Source: BSE
Intimation of closure of trading window.
26 Dec, 2025 | 04:45pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
26 Dec, 2025 | 10:13am • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
12 Dec, 2025 | 10:34am • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Kailash Shantilal Choudhari &...
06 Dec, 2025 | 11:15am • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
05 Dec, 2025 | 10:07am • Source: BSE
Financial Results for the Quarter & Half Year ended September 30, 2025
07 Nov, 2025 | 05:26pm • Source: BSE
Outcome of Board Meeting for Consideration & approval of financial results for the Quarter & Half Year ended September 30, 2025
07 Nov, 2025 | 05:16pm • Source: BSE
Aksh Optifibre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and...
29 Oct, 2025 | 04:57pm • Source: BSE
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
08 Oct, 2025 | 04:43pm • Source: BSE